Teneligliptin 20mg, Pioglitazone 15mg & Metformin Hydrochloride (Sustained Release) 1000mg Tablets – TENELIGOLD PM 1000

TENELIGOLD PM 1000, from Steris Healthcare, contains Teneligliptin 20mg, Pioglitazone 15mg & Metformin Hydrochloride (Sustained Release) 1000mg Tablets. This is a prescription oral antidiabetic combination used as part of the management of type 2 diabetes mellitus when multiple mechanisms are required to improve blood-glucose control.

The three medicines work through complementary pathways: teneligliptin helps increase glucose-dependent insulin release and reduce glucagon secretion, pioglitazone improves insulin sensitivity, and sustained-release metformin reduces hepatic glucose production while improving insulin sensitivity. This combination should be used only under medical supervision along with appropriate diet, physical activity and regular blood-glucose monitoring.

What is TENELIGOLD PM 1000 For?

TENELIGOLD PM 1000 is prescribed for adults with type 2 diabetes when lifestyle measures alone or other diabetes medicines do not provide adequate glycemic control.

The formulation combines three antidiabetic agents:

  • Teneligliptin 20mg: A DPP-4 inhibitor that helps increase glucose-dependent insulin secretion and reduce inappropriate glucagon release.

  • Pioglitazone 15mg: A thiazolidinedione that improves insulin sensitivity in tissues.

  • Metformin Hydrochloride SR 1000mg: A sustained-release biguanide that primarily reduces excessive glucose production by the liver and improves insulin sensitivity.

The combination is not intended for type 1 diabetes or diabetic ketoacidosis. Treatment should be individualized according to blood-glucose levels, kidney and liver function, other medicines and the patient's overall health.

Why It's Important 

Type 2 diabetes is a long-term metabolic condition requiring consistent management. Combining medicines that act through different pathways can improve glucose control in appropriately selected patients, but it can also increase the need for monitoring.

Metformin requires attention to kidney function, pioglitazone can cause fluid retention and weight gain, and teneligliptin may require consideration of other medicines and the patient's clinical condition.

TENELIGOLD PM 1000 should therefore be taken exactly as prescribed and should not be started, stopped or adjusted without medical advice. A balanced diet, regular physical activity and periodic HbA1c and blood-glucose testing remain important components of diabetes management.

Key Benefits 

What Are the Benefits of Teneligliptin 20mg, Pioglitazone 15mg & Metformin Hydrochloride SR 1000mg Tablets?

The major potential benefit of this combination is its multi-mechanism approach to blood-glucose control.

Potential therapeutic benefits include:

  • Helps lower elevated blood glucose in appropriate patients with type 2 diabetes

  • Combines three complementary glucose-lowering mechanisms

  • Teneligliptin supports glucose-dependent insulin secretion

  • Pioglitazone improves insulin sensitivity

  • Metformin reduces excessive hepatic glucose production

  • Sustained-release metformin provides a modified-release formulation

  • May help patients achieve individualized blood-glucose targets when prescribed appropriately

The medicine is not a replacement for dietary management or physical activity. Its effectiveness should be assessed using clinical parameters such as fasting glucose, post-meal glucose and HbA1c as recommended by the treating physician.

Mechanism of Action 

Teneligliptin 20mg

Teneligliptin is a DPP-4 inhibitor. It inhibits the enzyme dipeptidyl peptidase-4, which normally breaks down incretin hormones such as GLP-1 and GIP. Increasing incretin activity helps stimulate insulin secretion in a glucose-dependent manner and suppress glucagon secretion when blood glucose is elevated.

Pioglitazone 15mg

Pioglitazone is a thiazolidinedione (TZD) that activates PPAR-gamma receptors. This improves insulin sensitivity in adipose tissue, skeletal muscle and other tissues, helping the body use insulin more effectively and improving glucose utilization.

Metformin Hydrochloride SR 1000mg

Metformin primarily decreases hepatic glucose production and also improves peripheral insulin sensitivity. The sustained-release formulation is designed to release metformin gradually over time.

By acting through different pathways, the three medicines can provide complementary glucose-lowering effects in appropriately selected patients.

Side Effects 

Some patients may experience side effects, particularly when treatment is initiated or when the dosage is changed.

Possible side effects include:

  • Nausea

  • Diarrhea

  • Stomach discomfort

  • Abdominal bloating

  • Loss of appetite

  • Headache

  • Dizziness

  • Weight gain

  • Swelling of the legs or ankles

  • Upper-respiratory symptoms

Gastrointestinal effects are particularly associated with metformin and may improve as the body adjusts to treatment.

Pioglitazone may cause fluid retention and weight gain. The risk of hypoglycemia can increase when this combination is used with insulin or medicines such as sulfonylureas.

Serious Side Effects 

Seek urgent medical attention if you experience symptoms such as:

  • Severe or persistent weakness

  • Rapid breathing or difficulty breathing

  • Severe abdominal discomfort with vomiting

  • Unusual drowsiness or confusion

  • Significant swelling or sudden weight gain

  • Shortness of breath, particularly when lying down

  • Severe or persistent upper-abdominal pain

  • Yellowing of the skin or eyes

  • Signs of a serious allergic reaction

A rare but serious complication associated with metformin is lactic acidosis, particularly in patients with significant renal impairment or other risk factors. Prompt medical assessment is necessary if symptoms suggest this complication.

Pioglitazone can cause or worsen fluid retention and may exacerbate heart failure in susceptible individuals. Any new breathlessness, rapid weight gain or swelling should be reported promptly.

Available Substitute 

A substitute for TENELIGOLD PM 1000 should be selected according to the patient's diabetes treatment plan, HbA1c level, kidney function, cardiovascular status and tolerance of individual medicines.

Another combination may contain teneligliptin and metformin but omit pioglitazone, or it may use a different DPP-4 inhibitor, thiazolidinedione or metformin formulation. These products are not automatically equivalent.

If TENELIGOLD PM 1000 is unavailable, consult a doctor or pharmacist before switching. The substitute should match the required active ingredients, strengths and dosage form whenever clinically appropriate.

Dosage Guidelines 

The dosage of Teneligliptin 20mg, Pioglitazone 15mg & Metformin Hydrochloride (Sustained Release) 1000mg Tablets should be determined by the prescribing physician based on the patient's current diabetes regimen and glycemic response.

General administration guidance includes:

  1. Take the tablet exactly as prescribed.

  2. Take it with food if directed, which may help reduce gastrointestinal discomfort.

  3. Swallow the sustained-release tablet whole with water.

  4. Do not crush, split or chew the sustained-release tablet unless the specific product information states that it can be divided.

  5. Take the medicine at approximately the same time each day.

  6. Do not take an additional tablet to compensate for a missed dose without medical advice.

  7. Continue recommended diet, exercise and blood-glucose monitoring.

Do not discontinue diabetes treatment simply because glucose readings improve unless instructed by your doctor.

Precautions & Warnings 

Before using TENELIGOLD PM 1000, tell your doctor if you have:

  • Kidney disease or reduced kidney function

  • Liver disease

  • Heart failure or a history of significant heart problems

  • Bladder cancer or a history of bladder cancer

  • A history of pancreatitis

  • Severe dehydration

  • A condition that can cause low oxygen levels or poor circulation

  • A planned surgery or procedure

  • Regular alcohol consumption

  • A history of allergic reactions to any component

Kidney function should be assessed appropriately during metformin treatment. Pioglitazone requires particular caution in patients at risk of fluid retention or heart failure.

Conclusion

TENELIGOLD PM 1000 by Steris Healthcare contains Teneligliptin 20mg, Pioglitazone 15mg & Metformin Hydrochloride (Sustained Release) 1000mg Tablets, a prescription triple-combination therapy designed to improve blood-glucose control in appropriately selected adults with type 2 diabetes mellitus.

The formulation combines three complementary mechanisms: teneligliptin enhances glucose-dependent incretin activity, pioglitazone improves insulin sensitivity, and sustained-release metformin reduces hepatic glucose production while improving insulin sensitivity. This multi-mechanism approach may be useful when a single medicine or dual therapy does not adequately control blood glucose.

However, this combination requires appropriate medical supervision because its components have important safety considerations, including gastrointestinal effects, fluid retention, weight gain, hypoglycemia when combined with certain medicines and the rare risk of metformin-associated lactic acidosis.

For safe and effective use, take TENELIGOLD PM 1000 exactly as prescribed, swallow the sustained-release tablet appropriately, maintain recommended lifestyle measures and attend regular diabetes monitoring appointments. Never change the dose or discontinue treatment without consulting your healthcare professional.

Comments

Post a Comment

Popular posts from this blog

Steris Healthcare: Committed to Quality Healthcare and Pharmaceutical Excellence

 Healthcare is one of the most significant sectors influencing the well-being of individuals and communities. As medical science advances, the demand for reliable pharmaceutical products continues to grow. Patients, healthcare professionals, and medical institutions all depend on high-quality medicines that meet strict standards of safety and effectiveness. Pharmaceutical companies play a vital role in ensuring these products are developed, manufactured, and delivered responsibly. Steris Healthcare is committed to supporting better healthcare by providing quality pharmaceutical products designed to improve patient outcomes. Guided by innovation, integrity, and continuous improvement, the company strives to meet the evolving needs of the healthcare industry while maintaining high standards of quality and customer satisfaction. A Vision for Better Healthcare Every successful healthcare organization begins with a clear vision. Steris Healthcare believes that quality medicines and de...
Read more

N-Acetyl L-Cysteine (NAC), Pine Bark Extract and Resveratrol Tablets for Daily Wellness

Image
  N-Acetyl L-Cysteine (NAC), Pine Bark Extract & Resveratrol Tablets: Ingredients and Health Benefits Today’s lifestyle in India has changed a lot. Long working hours, stress, pollution, processed food, and lack of physical activity are affecting overall health. Many people feel tired, low on energy, or struggle with metabolic and hormonal balance tablet . One of the main reasons behind this is oxidative stress. Oxidative stress happens when harmful molecules called free radicals damage the body’s cells. Over time, this may affect immunity, liver health, heart health, skin, and overall wellness.  STYLECYSTIN ENDO is a specially designed antioxidant tablet that contains N-Acetyl L-Cysteine (NAC), Pine Bark Extract, and Resveratrol . This powerful combination supports cellular protection, improves antioxidant levels, and promotes better internal balance. It is commonly recommended as supportive therapy in metabolic conditions, women’s health concerns, and lifestyle-related ...
Read more
Megestrol Acetate 160 mg: MAGRAL 160 Uses, Benefits & Safety MAGRAL 160 contains Megestrol Acetate 160 mg and is marketed by Steris Healthcare . Megestrol acetate is a synthetic progestin that is used in specific clinical situations, particularly for managing anorexia, cachexia, or significant unexplained weight loss associated with advanced cancer or AIDS , depending on the approved indication and medical judgment. It is a prescription medicine and should be used under the supervision of a qualified healthcare professional. Megestrol acetate is not a general-purpose appetite booster or routine weight-gain medicine. Before treatment, the underlying reason for poor appetite or weight loss should be evaluated. What is MAGRAL 160 For? MAGRAL 160 may be prescribed when significant appetite loss or involuntary weight loss occurs in certain serious medical conditions. Megestrol acetate can help increase appetite and may contribute to weight gain in appropriately selected patients. Th...
Read more